BamSEC and AlphaSense Join Forces
Learn More

Odyssey Therapeutics, Inc. – Material Contracts

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 15 pages Share Purchase Agreement
12/34/56
EX-10.12
from S-1/A 12 pages Odyssey Therapeutics, Inc. 2021 Equity Incentive Plan Form of Restricted Stock Agreement
12/34/56
EX-10.6
from S-1/A 15 pages Form of Executive Employment Agreement
12/34/56
EX-10.5
from S-1/A 15 pages Executive Employment Agreement
12/34/56
EX-10.3
from S-1/A 16 pages Odyssey Therapeutics, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 52 pages Odyssey Therapeutics, Inc. 2026 Long-Term Incentive Plan
12/34/56
EX-10.10
from S-1 42 pages Membership Interest Purchase Agreement by and Among Odyssey Therapeutics, Inc., Ifm Therapeutics, LLC, Ifm Management, Inc., Ifm Therapeutics Gmbh Ifm Quattro, Inc., Ifm Cinque, Inc., and Ifm Continua, Inc. Dated as of May 6, 2022
12/34/56
EX-10.9
from S-1 45 pages Share Purchase Agreement Among Odyssey Therapeutics, Inc., Rahko Limited, Balderton Capital General Partner VI S.L.P and Robert Ian Horobin and Miriam Cha, as Sellers’ Representatives Dated as of October 6, 2021
12/34/56
EX-10.8
from S-1 50 pages Share Purchase Agreement Among Odyssey Therapeutics, Inc., Rahko Limited, Sellers, and Robert Ian Horobin and Miriam Cha, as Sellers’ Representatives Dated as of October 6, 2021
12/34/56
EX-10.7
from S-1 55 pages ***Certain Identified Information Has Been Omitted From This Exhibit Because It Is Both (I) Not Material and (II) of the Type That the Registrant Treats as Private or Confidential. Such Omitted Information Is Indicated by Brackets (“[***]”) in This Exhibit.***
12/34/56
EX-10.6
from S-1 7 pages Odyssey Therapeutics, Inc. Stock Restriction Agreement
12/34/56
EX-10.4
from S-1 11 pages Form of Indemnification Agreement
12/34/56
EX-10.1
from S-1 40 pages Odyssey Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.1
from DRS/A 40 pages Odyssey Therapeutics, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.12
from DRS 70 pages Membership Interest Purchase Agreement by and Among Odyssey Therapeutics, Inc., Ifm Therapeutics, LLC, Ifm Management, Inc., Ifm Therapeutics Gmbh Ifm Quattro, Inc., Ifm Cinque, Inc., and Ifm Continua, Inc. Dated as of May 6, 2022
12/34/56
EX-10.11
from DRS 72 pages Share Purchase Agreement Among Odyssey Therapeutics, Inc., Rahko Limited, Balderton Capital General Partner VI S.L.P and Robert Ian Horobin and Miriam Cha, as Sellers’ Representatives Dated as of October 6, 2021
12/34/56
EX-10.10
from DRS 77 pages Share Purchase Agreement Among Odyssey Therapeutics, Inc., Rahko Limited, Sellers, and Robert Ian Horobin and Miriam Cha, as Sellers’ Representatives Dated as of October 6, 2021
12/34/56
EX-10.9
from DRS 86 pages Collaboration and License Agreement by and Between Terray Therapeutics, Inc. and Odyssey Therapeutics, Inc. Dated September 11, 2024
12/34/56
EX-10.14
from S-1 70 pages Membership Interest Purchase Agreement by and Among Odyssey Therapeutics, Inc., Ifm Therapeutics, LLC, Ifm Management, Inc., Ifm Therapeutics Gmbh Ifm Quattro, Inc., Ifm Cinque, Inc., and Ifm Continua, Inc. Dated as of May 6, 2022
12/34/56
EX-10.13
from S-1 72 pages Share Purchase Agreement Among Odyssey Therapeutics, Inc., Rahko Limited, Balderton Capital General Partner VI S.L.P and Robert Ian Horobin and Miriam Cha, as Sellers’ Representatives Dated as of October 6, 2021
12/34/56